STOCK TITAN

Editas Medicine to Participate in Upcoming Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

On October 1, 2020, Editas Medicine (Nasdaq: EDIT) announced its participation in the Chardan Virtual 4th Annual Genetic Medicines Conference, scheduled for October 5, 2020, at 10:30 a.m. ET. The event will feature a fireside chat and will be webcast live on the company's website, with archived recordings available for 30 days post-event. Editas Medicine focuses on developing transformative genomic medicines using CRISPR technology to treat serious diseases. For more updates, visit www.editasmedicine.com.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that management will participate in the following upcoming investor conference:

Chardan Virtual 4th Annual Genetic Medicines Conference
Fireside Chat
Date: Monday, October 5, 2020
Time: 10:30 a.m. ET

The event will be webcast live and may be accessed on the Editas Medicine website in the Investors and Media section. Archived recordings will be available for approximately 30 days following the event.

About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Investor Contact
Mark Mullikin
(617) 401-9083
mark.mullikin@editasmed.com

Media Contact
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com

FAQ

What is the date of Editas Medicine's participation in the Chardan conference?

Editas Medicine will participate in the Chardan Virtual 4th Annual Genetic Medicines Conference on October 5, 2020.

What time will Editas Medicine's fireside chat start at the conference?

The fireside chat will start at 10:30 a.m. ET.

Where can I watch Editas Medicine's conference presentation?

The presentation will be webcast live on the Editas Medicine website in the Investors and Media section.

How long will the conference recording be available after the event?

Archived recordings will be available for approximately 30 days following the event.

What technology does Editas Medicine utilize in its treatments?

Editas Medicine utilizes CRISPR/Cas9 and CRISPR/Cas12a genome editing systems.

Editas Medicine, Inc.

NASDAQ:EDIT

EDIT Rankings

EDIT Latest News

EDIT Stock Data

203.89M
82.28M
0.32%
70.13%
20.88%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
CAMBRIDGE